ENABLEX Pages on BioPortfolio:

Biotechnology News ENABLEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/ENABLEX-news.htm...

BioPortfolio - Enablex
Enablex - BioPortfolio - Indepth. ... Press Releases About Enablex: BioPortfolio Logo. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) ...
http://www.bioportfolio.com/indepth/Enablex.html...

BioPortfolio.com - BioWeb VESICARE SOLIFENACIN SUCCINATE ...
Thanks in part to this, its sales will surge to $971m by 2011 while Enablex will reach $743m.- In the stress urinary incontinence sub-indication, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Urinary Incontinence: Growing market offers commercial opportunity
Of the two drugs expected to launch in 2004, Vesicare is expected to prove more popular than Enablex, backed by favorable results from a head-to-head study ...
http://www.bioportfolio.com/news/datamonitor_49.htm...

BioPortfolio - Healthcare Businesswomen's Association ...
Enablex Novartis Pharmaceuticals Corporation - Treatment for ... Enablex Novartis ... http://www.drugs.com/newdrugs/enablex-novartis-pharmaceutica. ...
http://www.bioportfolio.com/news/Healthcare-Businesswomen.pd...

BioPortfolio Limited Urinary Incontinence Lifecycle management ...
Enablex's clinical trial program and study designs 70. Efficacy of Enablex 71. Side effects of Enablex 71. Yentreve (duloxetine) 71. Drug overview 71 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_1052.html...

Urinary Incontinence Lifecycle management strategies retain ...
26 Dec 2007 ... At this point Detrol LA will be followed by the other second generation anticholinergics, GSK's Vesicare (solifenacin), Novartis' Enablex ...
http://www.bioportfolio.com/cgi-bin/acatalog/Urinary_Inconti...

New data published on KW-7158, a novel treatment of overactive bladder
29 Mar 2004 ... Vesicare is expected to prove more popular than Enablex, backed up by favorable results from a head-to-head study with Detrol. ...
http://www.bioportfolio.com/news/DailyUpdates_26.htm...

Datamonitor Pharmaceutical and Biotechnology Reports
... key brands expected to be Pfizer's Detrol LA (tolterodine) and Toviaz ( fesoterodine), GSK's Vesicare (solifenacin), and Novartis' Enablex (darifenacin)
. ...
http://www.bioportfolio.com/cgi-bin/acatalog/Datamonitor.htm...

Results from other life science and pharmaceutical sites:

ENABLEX®
ENABLEX is a once-a-day extended-release tablet and contains the following inactive ... After oral administration of ENABLEX to healthy volunteers, ...
http://www.pharma.us.novartis.com/product/pi/pdf/enablex.pdf...

ENABLEX | Industry information for ENABLEX
What was the percentage reduction in incontinence episodes at 2 years with ENABLEX® (darifenacin) in the open-label extension study? ...
http://www.medscape.com/infosite/enablex...

Enablex (darifenacin extended-release tablets) - Novartis ...
Information on the Novartis prescription medicine Enablex.
http://www.pharma.us.novartis.com/products/name/enablex.jsp...

ENABLEX | Industry information for ENABLEX
79% median reduction in incontinence episodes leading to a change in pads or clothing with ENABLEX 15 mg, regardless of severity (vs 55% with placebo)1* ...
http://www.medscape.com/infosite/enablex/article-4...

ENABLEX (darifenacin) tablet, extended release [Novartis ...
22 Dec 2004 ... ENABLEX® (darifenacin) is an extended-release tablet which contains 7.5 mg or 15 mg darifenacin as its hydrobromide salt. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=12961...

ENABLEX | Industry information for ENABLEX
Healthy volunteers on Detrol LA experienced a statistically significant increase in mean heart rate over 24 hours versus ENABLEX, while the change in mean ...
http://www.medscape.com/infosite/enablex/article-1...

Darifenacin - Wikipedia, the free encyclopedia
Darifenacin (trade name Enablex in US and Canada, Emselex in Europe) is a ... Enablex product website, run by Novartis Pharmaceuticals Corporation ...
http://en.wikipedia.org/wiki/Darifenacin...

ENABLEX | Industry information for ENABLEX
Doses were administered according to US prescribing information (ENABLEX 7.5 mg, weeks 1 and 2; ENABLEX 15 mg at week 3). The primary variable was accuracy ...
http://www.medscape.com/infosite/enablex/article-8...

INFORMATION FOR PATIENTS
Read the Patient Information that comes with ENABLEX® before you start ... healthcare professional can determine if treatment with ENABLEX is right for you
. ...
http://www.pharma.us.novartis.com/product/pi/pdf/enablex_PPI...

Enablex (darifenacin) Extended-Release Tablets
11 Jul 2009 ... Enablex (darifenacin) Extended-Release Tablets. Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/Safety-...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.